Trophoblasts Regulate the Placental Hematopoietic Niche through PDGF-B Signaling

Developmental Cell

Volumn 22, Issue 3, 2012, Pages 651-659

  Chhabra, Akanksha ^a   Lechner, Andrew J ^a   Ueno, Masaya ^a   Acharya, Asha ^d   Van Handel, Ben ^a   Wang, Yanling ^a   Iruela Arispe, M Luisa ^a,c   Tallquist, Michelle D ^d   Mikkola, Hanna K A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; PLATELET DERIVED GROWTH FACTOR B;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; EMBRYO; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; FEMALE; FETUS LIVER; GENE OVEREXPRESSION; GESTATION PERIOD; HYPOXIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER SIZE; MICROENVIRONMENT; MOUSE; NONHUMAN; PLACENTAL HEMATOPOIETIC NICHE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STEM CELL NICHE; TROPHOBLAST; UPREGULATION; VASCULARIZATION;

ANIMALS; CELL DIFFERENTIATION; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGES; MICE; PLACENTA; PREGNANCY; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TROPHOBLASTS;

EID: 84862803110     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2011.12.022     Document Type: Article

References (49)

1. Adams R.H., Porras A., Alonso G., Jones M., Vintersten K., Panelli S., Valladares A., Perez L., Klein R., Nebreda A.R. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 2000, 6:109-116.
2. Alvarez-Silva M., Belo-Diabangouaya P., Salaün J., Dieterlen-Lièvre F. Mouse placenta is a major hematopoietic organ. Development 2003, 130:5437-5444.
3. Anagnostou A., Lee E.S., Kessimian N., Levinson R., Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl. Acad. Sci. USA 1990, 87:5978-5982.
4. Andrae J., Gallini R., Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008, 22:1276-1312.
5. Bárcena A., Kapidzic M., Muench M.O., Gormley M., Scott M.A., Weier J.F., Ferlatte C., Fisher S.J. The human placenta is a hematopoietic organ during the embryonic and fetal periods of development. Dev. Biol. 2009, 327:24-33.
6. Bjarnegård M., Enge M., Norlin J., Gustafsdottir S., Fredriksson S., Abramsson A., Takemoto M., Gustafsson E., Fässler R., Betsholtz C. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 2004, 131:1847-1857.
7. Breier G., Clauss M., Risau W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev. Dyn. 1995, 204:228-239.
8. Carlini R.G., Reyes A.A., Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int. 1995, 47:740-745.
9. Chen M.J., Yokomizo T., Zeigler B.M., Dzierzak E., Speck N.A. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009, 457:887-891.
10. Chow A., Lucas D., Hidalgo A., Méndez-Ferrer S., Hashimoto D., Scheiermann C., Battista M., Leboeuf M., Prophete C., van Rooijen N., et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 2011, 208:261-271.
11. Conrad K.P., Benyo D.F., Westerhausen-Larsen A., Miles T.M. Expression of erythropoietin by the human placenta. FASEB J. 1996, 10:760-768.
12. Dame C., Fahnenstich H., Freitag P., Hofmann D., Abdul-Nour T., Bartmann P., Fandrey J. Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood 1998, 92:3218-3225.
13. Ebert B.L., Bunn H.F. Regulation of the erythropoietin gene. Blood 1999, 94:1864-1877.
14. Fairchild Benyo D., Conrad K.P. Expression of the erythropoietin receptor by trophoblast cellsin the human placenta. Biol. Reprod. 1999, 60:861-870.
15. Gekas C., Dieterlen-Lièvre F., Orkin S.H., Mikkola H.K. The placenta is a niche for hematopoietic stem cells. Dev. Cell 2005, 8:365-375.
16. Holmgren L., Glaser A., Pfeifer-Ohlsson S., Ohlsson R. Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. Development 1991, 113:749-754.
17. Holmgren L., Claesson-Welsh L., Heldin C.H., Ohlsson R. The expression of PDGF alpha- and beta-receptors in subpopulations of PDGF-producing cells implicates autocrine stimulatory loops in the control of proliferation in cytotrophoblasts that have invaded the maternal endometrium. Growth Factors 1992, 6:219-231.
18. Janmaat M.L., Heerkens J.L., de Bruin A.M., Klous A., de Waard V., de Vries C.J. Erythropoietin accelerates smooth muscle cell-rich vascular lesion formation in mice through endothelial cell activation involving enhanced PDGF-BB release. Blood 2010, 115:1453-1460.
19. Kaminski W.E., Lindahl P., Lin N.L., Broudy V.C., Crosby J.R., Hellström M., Swolin B., Bowen-Pope D.F., Martin P.J., Ross R., et al. Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice. Blood 2001, 97:1990-1998.
20. Kiel M.J., Morrison S.J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat. Rev. Immunol. 2008, 8:290-301.
21. Koury M.J., Bondurant M.C., Graber S.E., Sawyer S.T. Erythropoietin messenger RNA levels in developing mice and transfer of 125I-erythropoietin by the placenta. J. Clin. Invest. 1988, 82:154-159.
22. Lee R., Kertesz N., Joseph S.B., Jegalian A., Wu H. Erythropoietin (Epo) and EpoR expression and 2 waves of erythropoiesis. Blood 2001, 98:1408-1415.
23. Levéen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 1994, 8:1875-1887.
24. Lin J., Poole J., Linzer D.I. Two novel members of the prolactin/growth hormone family are expressed in the mouse placenta. Endocrinology 1997, 138:5535-5540.
25. Linch D.C., Knott L.J., Rodeck C.H., Huehns E.R. Studies of circulating hemopoietic progenitor cells in human fetal blood. Blood 1982, 59:976-979.
26. Marine J.C., McKay C., Wang D., Topham D.J., Parganas E., Nakajima H., Pendeville H., Yasukawa H., Sasaki A., Yoshimura A., Ihle J.N. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 1999, 98:617-627.
27. Mikkola H.K., Orkin S.H. The journey of developing hematopoietic stem cells. Development 2006, 133:3733-3744.
28. Ohlsson R., Falck P., Hellström M., Lindahl P., Boström H., Franklin G., Ahrlund-Richter L., Pollard J., Soriano P., Betsholtz C. PDGFB regulates the development of the labyrinthine layer of the mouse fetal placenta. Dev. Biol. 1999, 212:124-136.
29. Okada Y., Ueshin Y., Isotani A., Saito-Fujita T., Nakashima H., Kimura K., Mizoguchi A., Oh-Hora M., Mori Y., Ogata M., et al. Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer. Nat. Biotechnol. 2007, 25:233-237.
30. Ottersbach K., Dzierzak E. The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev. Cell 2005, 8:377-387.
31. Palis J., Chan R.J., Koniski A., Patel R., Starr M., Yoder M.C. Spatial and temporal emergence of high proliferative potential hematopoietic precursors during murine embryogenesis. Proc. Natl. Acad. Sci. USA 2001, 98:4528-4533.
32. Rhodes K.E., Gekas C., Wang Y., Lux C.T., Francis C.S., Chan D.N., Conway S., Orkin S.H., Yoder M.C., Mikkola H.K. The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell 2008, 2:252-263.
33. Roberts A.W., Robb L., Rakar S., Hartley L., Cluse L., Nicola N.A., Metcalf D., Hilton D.J., Alexander W.S. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc. Natl. Acad. Sci. USA 2001, 98:9324-9329.
34. Robin C., Bollerot K., Mendes S., Haak E., Crisan M., Cerisoli F., Lauw I., Kaimakis P., Jorna R., Vermeulen M., et al. Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. Cell Stem Cell 2009, 5:385-395.
35. Sasaki A., Yasukawa H., Shouda T., Kitamura T., Dikic I., Yoshimura A. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J. Biol. Chem. 2000, 275:29338-29347.
36. Sawyer S.T., Krantz S.B., Sawada K. Receptors for erythropoietin in mouse and human erythroid cells and placenta. Blood 1989, 74:103-109.
37. Serikov V., Hounshell C., Larkin S., Green W., Ikeda H., Walters M.C., Kuypers F.A. Human term placenta as a source of hematopoietic cells. Exp. Biol. Med. (Maywood) 2009, 234:813-823.
38. Simmons D.G., Cross J.C. Determinants of trophoblast lineage and cell subtype specification in the mouse placenta. Dev. Biol. 2005, 284:12-24.
39. Simmons D.G., Fortier A.L., Cross J.C. Diverse subtypes and developmental origins of trophoblast giant cells in the mouse placenta. Dev. Biol. 2007, 304:567-578.
40. Simmons D.G., Rawn S., Davies A., Hughes M., Cross J.C. Spatial and temporal expression of the 23 murine Prolactin/Placental Lactogen-related genes is not associated with their position in the locus. BMC Genomics 2008, 9:352.
41. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 1994, 8:1888-1896.
42. Tallquist M., Kazlauskas A. PDGF signaling in cells and mice. Cytokine Growth Factor Rev. 2004, 15:205-213.
43. Tamura K., Sudo T., Senftleben U., Dadak A.M., Johnson R., Karin M. Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 2000, 102:221-231.
44. Trollmann R., Strasser K., Keller S., Antoniou X., Grenacher B., Ogunshola O.O., Dötsch J., Rascher W., Gassmann M. Placental HIFs as markers of cerebral hypoxic distress in fetal mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R1973-R1981.
45. Wu H., Liu X., Jaenisch R., Lodish H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995, 83:59-67.
46. Yasuda Y., Okano M., Nagao M., Masuda S., Fujita Y., Sasaki R. Erythropoietin and erythropoietin-receptor producing cells demonstrated by in situ hybridization in mouse visceral yolk sacs. Anat. Sci. Int. 2002, 77:58-63.
47. Zeigler B.M., Sugiyama D., Chen M., Guo Y., Downs K.M., Speck N.A. The allantois and chorion, when isolated before circulation or chorio-allantoic fusion, have hematopoietic potential. Development 2006, 133:4183-4192.
48. Zhang J., Socolovsky M., Gross A.W., Lodish H.F. Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 2003, 102:3938-3946.
49. Zovein A.C., Hofmann J.J., Lynch M., French W.J., Turlo K.A., Yang Y., Becker M.S., Zanetta L., Dejana E., Gasson J.C., et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 2008, 3:625-636.